United States — Food and Drug Administration & Patrick Soon-Shiong
4 shared events · Importance 3 · Last updated Jun 03, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
United States — Food and Drug Administration: The United States — Food and Drug Administration issued a warning letter to ImmunityBio regarding misleading efficacy claims made by Patrick Soon-Shiong about Anktiva, which triggered the stock price drop and subsequent lawsuits.
Patrick Soon-Shiong: Patrick Soon-Shiong, ImmunityBio's Executive Chairman and Chief Scientific and Medical Officer, is accused of materially overstating Anktiva's capabilities, leading to the FDA warning and subsequent lawsuits.
Apr 02, 2026 · 132 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States — Food and Drug Administration and Patrick Soon-Shiong interact across events, view sentiment trends, and discover connected entities.
Open Dashboard